Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)

Peripheral vascular interventions
Number of report

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for endovascular repair (EVAR) of abdominal aortic aneurysm (AAA).

Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations). 

Only EVAR for unruptured aneurysm is considered.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of devices for aortic stent graft for treatment of abdominal aortic aneurysm include:

  • Bolton Medical (Treovance)
  • Cook Medical (Zenith Flex)
  • Cordis (Incraft)
  • Endologix (Nellix, Ovation iX, Powerlink, Eptfe AFX, AFX2)
  • Gore (Excluder)
  • Lombard Medical (Aorfix)
  • Medtronic (AneuRx, AAAdvantage, Talent, Endurant II)
  • Vascutek (Anaconda)

Table of content is not available at the moment. Report is still ongoing.


Aug 2022

On July 20, 2022, Health Institute Carlos III released two HTA reports regarding endoanchoring systems in endovascular aortic aneurysm repair and transanal irrigation in bowel dysfunction.

Read more


Aug 2022

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on using new and existing health technologies, likely to significantly impact healthcare. In July 2022, SHTG published three reports (KardiaMobile for detecting atrial fibrillation, complex endovascular aneurysm repair, and Togetherall platform). Currently, the SHTG is working on assessments of technologies in the field of cancer, radiotherapy, musculoskeletal diseases, transplantation, and other topics.

Read more


May 2022

In May 2022, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (endoanchoring systems in endovascular aortic aneurysm repair, supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis, personalized external aortic root support using mesh in people with Marfan syndrome), one Medical Technologies Guidance (Sleepio to treat insomnia and insomnia symptoms), and six Medtech innovation Briefings (ViewSite Brain Access System, Granulox for managing chronic wounds, AMBLor for identifying melanomas, Bladder EpiCheck for detecting bladder cancer recurrence, and others). No MedTech-related clinical guidelines were published.

Read more


Apr 2022

On March 31, 2022, NHS Digital released HRG4+ Local Payment Grouper for 2022/23 for use from April 01, 2022. In general, there are significant changes in base HRG design. A total of 120 new HRGs were created, and multiple HRGs were removed, so the total number increased by 62 from 2,838 to 2,900.

Read more


Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.

Read more
(we accept only company emails)